
    
      This trial is a prospective, multi-center, 1:1 randomized using endovenous radiofrequency
      closure catheter and endovenous radiofrequency closure generator versus ClosureFast™ and
      ClosureRFG™ to treat varicose veins of lower extremity. And parimary endpoint is Complete
      closure rate of great saphenous vein at 6 months post-procedure.
    
  